- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03345654
Individually-guided Hearing Aid Fitting
October 25, 2023 updated by: Pamela Souza, Northwestern University
Characterizing Variability in Hearing Aid Outcomes Among Older Adults
This translational project aims to optimize the fitting of hearing aids by development and clinical validation of a toolset that guides signal processing choice based on the individual auditory and cognitive abilities of the patient.
Study Overview
Detailed Description
The clinical trial portion of the project will validate clinical use of the toolset by evaluating a population of patients fit using current standard of care.
Patient characteristics, such as audiological profile and cognition, will be collected.
Their hearing aid settings will then be evaluated to determine if they meet toolset guidelines for signal processing based on their patient characteristics (auditory and cognition).
Data regarding subjective and objective hearing aid outcomes will also be collected.
It is hypothesized that hearing aid fittings that meet the standards of the proposed clinical toolset will result in better patient outcomes (objective and subjective) and fewer post-fitting visits.
Study Type
Observational
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kendra Marks, AuD
- Phone Number: 847-467-0897
- Email: kendra.marks@northwestern.edu
Study Contact Backup
- Name: Pamela Souza, PhD
- Phone Number: 847-491-2433
- Email: p-souza@northwestern.edu
Study Locations
-
-
Illinois
-
Evanston, Illinois, United States, 60208
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Population will be recruited from the Northwestern University Center for Audiology, Speech, Learning, and Language.
They will be adults (18+) who are new hearing aid users with no recent prior hearing aid experience.
Any patient at the clinic who purchases a new pair of hearing aids and meets the study criteria will be provided information about the study.
Description
Inclusion Criteria:
- sensorineural hearing loss with pure-tone thresholds 70 dB HL or better at octave frequencies between 250 and 4000 Hz, 4 (.5, 1, 2, 3 kHz)
- frequency pure-tone average (PTA) of ≥ 30 dB HL.
- Listeners will have symmetrical losses, defined here as a 4-frequency PTA difference between ears ≤ 20 dB HL.
Exclusion Criteria:
- recent (within last 12 months) hearing aid use
- conductive loss (air-bone gaps > 10 dB at any frequency and/or abnormal immittance) -
- scoring < 23 on the Montreal Cognitive Assessment
- Hearing loss exceeding the limits that can be successfully aided with hearing aids (i.e., profound hearing loss)
- Hearing loss remediated with a cochlear implant (cannot wear hearing aids)
- Significant history of otologic or neurologic disorders
- Non English speaking participants
- Any clinically significant unstable or progressive medical condition
- Any condition which, in the opinion of the investigator, places the participant at unacceptable risk if he or she were to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
New Hearing Aid Users fit with standard-of-care
Adults (18+) with hearing loss and newly fit with hearing aids
|
The signal processing of newly fit hearing aids will be evaluated for acceptability based on the toolset, which takes additional patient information beyond hearing threshold (like cognition) to determine the optimal hearing aid signal processing strategies.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speech intelligibility
Time Frame: Baseline at initial fit, then post-intervention at final hearing aid appointment, about 30 days later
|
Repeat low-context sentences
|
Baseline at initial fit, then post-intervention at final hearing aid appointment, about 30 days later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-fitting adjustment visits
Time Frame: First 30 days of fitting
|
Number of times hearing aid adjustments are made post-fitting
|
First 30 days of fitting
|
Speech and Spatial qualities questionnaire (SSQ)
Time Frame: Baseline at initial fit, then post intervention at final hearing aid appointment, about 30 days later
|
Questionnaire evaluating subjective perception of hearing ability in different environments
|
Baseline at initial fit, then post intervention at final hearing aid appointment, about 30 days later
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 22, 2023
Primary Completion (Estimated)
April 1, 2024
Study Completion (Estimated)
April 1, 2024
Study Registration Dates
First Submitted
November 14, 2017
First Submitted That Met QC Criteria
November 14, 2017
First Posted (Actual)
November 17, 2017
Study Record Updates
Last Update Posted (Actual)
October 30, 2023
Last Update Submitted That Met QC Criteria
October 25, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01DC012289-06 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Otologic Pharmaceutics, Inc.CompletedHearing Loss | Sensorineural Hearing Loss | Noise-Induced Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Hearing Aids
-
Sonova AGToronto Metropolitan UniversityNot yet recruiting
-
University Hospital, ToursCompletedHearing Loss | Alzheimer's DiseaseFrance
-
Jong Woo ChungCompletedAuditory Processing Disorder, CentralKorea, Republic of
-
Sonova AGCompletedSensorineural Hearing LossSwitzerland
-
Sonova AGWestern University, Canada; Sonova Canada Inc.Recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHearing Loss, Sensorineural | Cognitive Function Abnormal | Age-related Hearing Loss | Hearing AidChina
-
VA Office of Research and DevelopmentCompleted
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Technical University of DenmarkCompleted
-
Northwestern UniversityActive, not recruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, BilateralUnited States